PROJECTS
>>Ramp up of Product Development Efficiencies
>>Transformation through In-Licensing & Site Transfers
>>Out-License of New Molecular Entity by Biotech Footprint Late
>>Strengthening of Overseas Footprint
>>Divestment of Late Life Cycle Products
>>Commercializing a Reformulated Product
>>Business Development for Development Stage Enabling Technology
>>Restructuring Clinical Operations
>>Optimal Drug Development Path and Licensing Process
>>Post-Merger integration of Research and Development operations
Restructuring Clinical Operations
A US-based biotechnology company planned to significantly increase clinical trial work with an expanding Indian organization. The existing infrastructure was deemed incapable of delivering the projected number of clinical sites and subjects and to maintain high quality standards. The organization also desired higher site and country productivity in Asia & Europe. The Garphi team completed a detailed diagnostic investigation, including interviews with all affiliates to define issues and identify options, analyzed the data and proposed a new organization & some practical recommendations. The program was approved and successfully implemented.
